Carmella Evans-Molina

55PUBLICATIONS
204CO-AUTHORS
Digital literatureGene expression (incl. microarray and other genome-wide approaches)Medical molecular engineering of nucleic acids and proteinsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jun 26, 2026
SARS-CoV-2 and diabetes: a post-pandemic reappraisal.

|May 12, 2026
Heterogeneous endocrine cell composition defines human islet functional phenotypes.

|Apr 21, 2026
Beta cell microRNAs function as molecular hubs of type 1 diabetes pathogenesis and as biomarkers of diabetes risk.

|Mar 12, 2026
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.

Carmella Evans-Molina, Stephen E Gitelman, Andrea Mari

|Jan 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Carla J Greenbaum, S Alice Long, Stephen E Gitelman

|Dec 27, 2025
Altered B cell metabolic pathways characterize type 1 diabetes progression.

Holly Conway, Jessica Bernard, Rachel Ramos

Pageof 10

Frequent Collaborators

9 joint publications

Raghavendra G Mirmira

9 joint publications

Emily Sims

6 joint publications

Maria J Redondo

6 joint publications

Linda A DiMeglio